Recent study has been reported that that MLN4924, a small molecule inhibitor of neddylation modification, it induces mitochondrial fission-to-fusion conversion in breast cancer cells through suppressing degradation of fusion-promoting protein mitofusin1 (MFN1) and ubiquitylation by SCFβ-TrCP E3 ligase32. Here, MFN1 is linked to breast cancer.